The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85z. The seropositive rate was 25.89z for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0-5 years and elderly people aged AE60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26z of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies.
. Worldwide transmission of A(H1N1)pdm09 continued, and most countries experienced one or two epidemic waves before the end of the pandemic (7) (8) (9) (10) . As of August 10, 2010 , WHO declared that the influenza A pandemic had ended; more than 206 countries and overseas territories or communities had reported laboratory-confirmed cases of A(H1N1)pdm09, and there were over 6,250 deaths. In Shandong Province, China, the first laboratoryconfirmed case was identified on May 12, the first severe case was reported on September 23, and the first fatal case was reported on November 16. As of August 31, 2010, a total of 4,034 laboratory-confirmed A(H1N1)pdm09 cases and 231 laboratory-confirmed severe cases were reported to the Shandong Center for Disease Prevention and Control, and 50 patients with severe infection died. The main wave of the pandemic occurred in weeks 41 to 52 of 2009. In response to the influenza pandemic, a free vaccination program was implemented in Shandong Province starting in October 2009.
If corrected for vaccination status, data from seroprevalence studies of antibodies against A(H1N1)pdm09, performed after the pandemic (August 10, 2010), allow for a much better estimation of the cumulative incidence of A(H1N1)pdm09 infections than case surveillance data (11) . A seroepidemiololgy study was performed from August 20, 2010 to September 10, 2010 to better understand the population's immunity against A(H1N1)pdm09 in Shandong Province after the pandemic and to investigate factors influencing the risk for seropositivity. Moreover, this may provide useful information for national public health authorities in preparing for future influenza outbreaks.
MATERIALS AND METHODS
Epidemiology survey and speciman collection: The cross-sectional studies were conducted in August and September of 2010. Multistage stratified random sampling methods were used for subject selection. There are 17 districts in Shandong Province. For this study, two city districts and one countryside district were randomly selected from different geographic locations using a random digits table. The remainder of the multistage random sampling method was carried out by each district.
The method was carried out according to the method used by Xu et al. (12) .
Informed consent was obtained from study participants or guardians. The survey questionnaire included the subject's age, gender, type of residence, family members (whether they had children in school), history of respiratory tract infections, presence/absence of influenza-like symptoms, and vaccination history of both seasonal influenza (from 2007 to 2009) and pandemic H1N1; the questionnaire was completed by a trained interviewer and the blood samples were collected.
This study was approved by the institutional ethics review board at Shandong Center for Disease Control and Prevention.
Laboratory testing: The hemagglutination-inhibition (HI) assay using 0.5z turkey erythrocytes was used to test the serum for antibodies against A(H1N1)pdm09, according to standard protocols (13, 14) , with the A/California/07/2009 virus as the A(H1N1)pdm09 antigen. Serum samples were titrated in 2-fold dilutions in phosphate-buffered saline and tested at an initial dilution of 1:10. The titrations (AE1:40) were used as a marker for immunity against A(H1N1)pdm09 in this study. For assessing the within-laboratory reproducibility, 5z of serum samples randomly selected from all samples was tested.
Statistical analysis: EpiData software was used to develop the data set. Statistical analyses were performed with SPSS 17.0 software (SPSS Inc., Chicago, Ill., USA). The seropositive rates in the different groups were compared by the x 2 test or Fisher's exact tests. The multivariate logistic regression model was used to investigate the potential correlative factors that influenced the frequency and distribution of A(H1N1)pdm09 antibodies in different groups. The significance level for entering the multivariate logistic regression model was set as 0.05, and the level for staying in the model was 0.05. A P value of º0.05 was considered to be statistically significant.
RESULTS
General information of the study subjects: In August and September of 2010, we enrolled 4,549 subjects in the cross-sectional study. All participants completed both the questionnaire and blood sample collection. There were no statistically significant differences in the distribution of the data by age group, gender, region, and community setting (capital city, urban area, or rural area) between the study subjects and the true Shandong Province population. Among the subjects, 2,099 (46.14z) reported a history of cold symptoms since May 1, 2009. There were 405 (8.9z) subjects who reported receiving the pandemic H1N1 vaccine as compared to 4,144 (91.10z) who reported not receiving the pandemic H1N1 vaccine in the study. Among the unvaccinated participants, 43.58z were kindergarten children or students, 3.43z were children in family care, 2.44z were teachers, doctors, or nurses, 18.89z were farmers, and 31.66z belonged to other professions. The detailed demographic characteristics of the subjects are listed in Table 1 .
Pandemic H1N1 seropositive rate in the study subjects: In the post-pandemic period, 1,176 of the 4,549 study subjects were positive for antibodies (HI titer, AE1:40) against A(H1N1)pdm09; the seropositive rate was 25.85z (95z confidence interval [CI], 24.58z -27.12z). Antibody titers ranged from º1:10 to 1:1,280. Table 1 shows the distribution of the seropositive rates in various age groups in the total study group. The highest seropositive rate was observed in the 0-5 years age group. The partition of x 2 test was used to compare the differences among the different age groups, and a significant difference was found among these five groups based on a seropositive rate ( x 2 ＝ 43.16, P º 0.01). The seropositive rate of A(H1N1)pdm09 antibody response for the subjects who reported receiving vaccine was 25.43z (95z CI, 21.19z-29.69z), which was the same as that for subjects who did not report receiving the vaccine 25.89z (95z CI, 24.56z-27.22z) (x 2 ＝ 0.002, P À 0.05). The detailed seroprevalence of A(H1N1)pdm09 is listed in Table 1 .
Among the unvaccinated study population, the seropositive rates in various age groups ranged from 20.92z to 33.76z with the highest proportion seen in the 0-5 years age group; however, the seropositive rates varied greatly between age groups ( x 2 ＝ 48.11, P º 0.001). The seropositive rates for the male and female groups among the unvaccinated study population were 27.13z and 24.99z ( x 2 ＝ 2.42, P ＝ 0.120), respectively. Furthermore, among the unvaccinated subjects, the seropositive rate in rural areas (34.29z) was statistically significantly higher than the seropositive rates in the capital city (22.02z) and other urban cities (21.93z) (x 2 ＝ 71.10, P º 0.001) ( Table 1 ). In addition, different occupational groups displayed significant variation in their seropositive rates ( x 2 ＝ 132.22, P º 0.001), with children in family care having the highest rate of 47.89z, followed by teachers with 36.84z, farmers with 34.23z, and kindergarten children with 31.75z. Except for fever, history of cold and cough symptoms since May 1, 2009 was not associated with increased risk for seropositivity ( x 2 ＝ 4.58, P ＝ 0.032).
To control for possible interactions between factors, multivariable logistic regression was used to estimate the odds ratio (OR) and 95z CI for factors associated with A(H1N1)pdm09 antibody response among subjects who had not received the pandemic H1N1 vaccine ( Table 2) 
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DISCUSSION
The 2009 pandemic influenza was a challenge to the global public health response. However, it has been reported that many A(H1N1)pdm09 cases were mild (15) (16) (17) , and many of those with infection may not have sought medical care and would not have been tested for infection. Thus, the number of reported cases does not give a true picture of the actual infection rate. Serological survey is a helpful tool for understanding the infection rates and state of population immunity after infection, especially in the post-pandemic period.
According to our results, after excluding individuals who reported receiving the pandemic H1N1 vaccine, the prevalence in the post-pandemic period was 25.89z. Thus, the prevalence is higher than that in Taiwan (18), Hong Kong (7), Australia (19) , New Zealand (20) , Guangdong, China (21), Ontario (22) , and Greece (23); whereas, it is lower than that in Germany (24) and is the same as that in Thailand (25) . Therefore, in Shandong Province, the infected population was estimated to be 23.69 million.
Our study had several limitations. First, the study was conducted 9 months after the second wave of the epidemic in Shandong Province. Antibody decay to a level lower than the defined threshold may have occurred in some subjects (22) . Further, recent studies suggest that not all subjects developed seroprotection after A(H1N1)pdm09 infection and that the antibody level appears to be associated with disease severity at presentation (26, 27) . Second, we conducted a seroprevalence study following the post-pandemic period. We did not have baseline (pre-pandemic) data for accurately inferring the attack rates among the population in Shandong Province. However, the baseline serum samples collected from individuals in China prior to May 2009 had shown a very low positive rate (1.2z) against A(H1N1)pdm09 (12) . Third, the HI assay may not be the most sensitive assay for detecting low levels of A(H1N1)pdm09 (e.g., when compared to microneutralization); thus, we may have underestimated seropositivity in the serological survey samples. Finally, the study was conducted in three regions of Shandong Province, and the seroprevalence data may not be generalized to the entire population of Shandong Province. We noted that the seropositivity rate varied significantly from region to region. However, the impact of these geographic differences was controlled in the multivariate analysis of epidemiological risks. Unlike studies in other countries such as Germany, Greece, and Australia, our study showed that the preschool population had the highest attack rates of A(H1N1)pdm09, which is consistent with the influenzalike illness (ILI) in Shandong Province. According to the ILI data of Shandong Province from May 2009 to September 2010, the age-specific ILI was 40.76z (0-5 years), 24.85z (5-14 years), 17.22z (15-24 years), 13.90z (25-59 years), and 3.253z (À60 years). The seropositive rate (27.99z) was higher in the AE60 years age group than that in other age groups; however, the seropositive rate was not higher than that in the 0-5 years age group. These results are consistent with those reported in Ontario (33.3z) (22) and Pittsburgh (40z) (28) , which showed a higher seropositive rate in the AE60 years age group at the end of the influenza season and October 2010. However, the results were discordant with those of reports from Taiwan (11.8z) (18) and Greece (14.4z) (23) that were carried out in September and June 2010. Overall, the study showed that the highest percentage of individuals with antibodies to A(H1N1)pdm09 were children. Those aged À60 years may have cross-reactive antibodies to A(H1N1)pdm09 (29) (30) (31) .
The survey showed that the seroprevalence of A(H1N1)pdm09 infection was higher in the rural areas as compared to that in the capital city and other urban areas. It was also higher among children in family care and farmers, which was discordant with data from Beijing and Greece. The main reason is that Shandong Province is an agricultural province, and farmers account for 70z of the population. Second, the A(H1N1)pdm09 outbreak was transmitted from the city to rural areas. The time interval between infection with the virus to serum sample collection was short; hence, the antibody titer may have been within the defined threshold. The incidence of infection among doctors, nurses, and teachers was higher than that reported from Hong Kong (32), but lower than that reported from Greece. The seropositivity of unvaccinated and vaccinated subjects was similar because 82.3z of vaccinated subjects had received 1 dose of pandemic H1N1 vaccine prior to January 2010; therefore, antibody decay resulted in an antibody level that was lower than the defined threshold after 6 months.
Multivariate logistic regression revealed that the rural areas had significantly higher OR of A(H1N1)pdm09 seropositivity than the capital city and other urban areas. Individuals of all professions, except for teachers, had significantly lower OR of A(H1N1)pdm09 seropositivity than children in family care; this was discordant with the report of Xu et al. (12) . In addition, the symptoms (cold, fever, and cough) were not significantly associated with the seropositive rate.
In summary, the overall seroprotection rate increased to approximately 25.85z in the whole population and to 25.89z in the unimmunized population after the post-pandemic period, with statistically different rates among the different age groups, occupations, and regions. Young children aged 0-5 years and elderly people aged AE60 years showed the highest seropositive rate. The findings of this seroepidemiology study provide valuable data for understanding the epidemiology of the 2009 pandemic and planning future intervention strategies. In addition, it highlights the significance of seroprevelance studies at the country level.
